Reference 43 - An initial investigation of serum cytokine levels in patients with gadolinium retention

NonrulemakingSupporting & Related MaterialFDA-2026-P-6737-0045
🔔 Subscribe
Document

Details

The document's own metadata, straight from regulations.gov.

Posted
Jun 15, 2026
Agency
Food and Drug Administration (FDA)
© 2026 Government Context · not affiliated with any U.S. government agencyPrivacyTermsDockets